Unternehmen BFK Capital Corp Toronto S.E.
Aktien
BFKp
CA05543X1006
BFKp
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
||
- | - |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Charles Bowman
CEO | Chief Executive Officer | - | 08.02.21 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 15.06.22 |
Mona Matta
HRO | Human Resources Officer | - | 01.01.18 |
Jackie Fletcher
PRN | Corporate Officer/Principal | - | 14.12.21 |
Joelle Maurais
LAW | General Counsel | - | 01.04.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 51 | 12.07.22 | |
Hélène Fortin
BRD | Director/Board Member | 66 | - |
Mark Attanasio
CHM | Chairman | 47 | 22.02.22 |
Vincent Chiara
BRD | Director/Board Member | - | 04.11.16 |
Roger Savell
BRD | Director/Board Member | - | 12.07.22 |
Robin Godfrey
BRD | Director/Board Member | 51 | 22.02.22 |
William Montour
BRD | Director/Board Member | - | 05.01.22 |
Peter Montour
BRD | Director/Board Member | - | 30.08.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 43 996 355 | 42 034 185 ( 95,54 %) | 0 | 95,54 % |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+27.04% | 4.15 Mrd. | |
+127.59% | 2.3 Mrd. | |
+169.84% | 99.91 Mio. |
- Börse
- Aktien
- A2QQGC Aktie
- BFKp Aktie
- Unternehmen BFK Capital Corp